抄録
Thirteen patients under an intensified regimen in which regular insulin was being administered 3-4-times a day were selected for our study. In order to improve both postprandial glucose control and QOL for these patients, the regular insulin was changed to rapid-acting human insulin analogues.
Self-monitoring of blood glucose (SMBG) was conducted and glycosylated hemoglobin A (1C) (HbA1c), rate of hypoglycemic episodes, and body mass index were also monitored. In our role of pharmacist/Certified Diabetes Educator, wead-justed the doses in accordance with patient symptoms under the guidance of their doctors.
Patients' comments were obtained and from them, their sense of unease before and after the change was investigated. Pharmaceutical care, nutrition control, and counseling were carried out on the basis of the results in order to keep the patients in an appropriate state in accordance with their symptoms. Regardless of variation in insulin doses, their QoL improved and incidence of hypoglycemia decreased. Patient autonomy and compliance were also enhanced.
